Queue Ventures Announces Results of Special Meeting of Custom Health, Inc. in Connection With Previously Announced Plan of Arrangement
May 7, 2026
Queue Ventures Ltd. | Access Newswire
Custom shareholders voted in favour of the resolution to approve the Company’s previously announced plan of arrangement with Queue Ventures — a key step toward becoming a publicly traded company and advancing a scalable, infrastructure-led model for medication management and clinical care.
The transaction remains subject to final TSX approval and customary closing conditions.
This update includes forward-looking statements regarding the proposed transaction and listing. Actual results may differ materially.







